Moreover, targeting RSK4 O-GlcNAcylation with OSMI-4 destabilizes RSK4 and sensitizes ESCC to radiotherapy in both patient-derived xenograft and organoid models. The gene discussed is RPS6KA6; the disease is esophageal squamous cell carcinoma.